Norbert Furtmann

Sanofi (France) — France

Computer Science · Physical Sciences

17h-index847citations53works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(11), Monoclonal and Polyclonal Antibodies Research(6), Synthesis and biological activity(5), Protease and Inhibitor Mechanisms(5), Crystallization and Solubility Studies(5)

Publications53 total

SNAC-DB: Structural NANOBODY® (VHH) and Antibody (VH-VL) Complex Database
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodies
Scientific Reports·2026Open Access
Deep Batch Active Learning for Protein Structure Modeling
Journal of Computational Biology·2026
Die Umlenkung der Peptidspaltung führt zur Protease‐Inaktivierung
Angewandte Chemie·2025Open Access
Redirecting the Peptide Cleavage Causes Protease Inactivation
Angewandte Chemie International Edition·2025Open Access
How to think about designing smart antibodies in the age of genAI: integrating biology, technology, and experience
mAbs·2025· 6 citedOpen Access
Best practices for machine learning in antibody discovery and development
Drug Discovery Today·2024· 15 citedOpen Access
Computational Screening for mAb Colloidal Stability with Coarse-Grained, Molecular-Scale Simulations
The Journal of Physical Chemistry B·2024· 4 cited
Best practices for machine learning in antibody discovery and development
arXiv (Cornell University)·2023· 1 citedOpen Access
High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass Spectrometry
Analytical Chemistry·2023· 6 cited
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Nature Communications·2023· 15 citedOpen Access
A trispecific Ab directed to HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Research Square (Research Square)·2022Open Access
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics
mAbs·2021· 19 citedOpen Access
Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies
Medicinal Chemistry·2018· 1 cited
Chalcone Isomerase from Eubacterium ramulus Catalyzes the Ring Contraction of Flavanonols
Journal of Bacteriology·2016· 45 citedOpen Access
Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors
Bioorganic Chemistry·2016· 60 citedOpen Access
Back Cover: Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity‐Based Probes of Matriptase‐2 (Chem. Eur. J. 25/2016)
Chemistry - A European Journal·2016
Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity‐Based Probes of Matriptase‐2
Chemistry - A European Journal·2016· 24 cited
Cover Picture: En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase‐2 as a Target for Kunitz‐Type Inhibitors (ChemBioChem 7/2016)
ChemBioChem·2016Open Access
En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase‐2 as a Target for Kunitz‐Type Inhibitors
ChemBioChem·2016· 25 cited
page 1 of 3Next →

Frequent Co-authors

Jürgen Bajorath(38), Michael Gütschow(20), Jamshed Iqbal(12), Ye Hu(10), Marit Stirnberg(8), Abdul Hameed(7), Khalid Mohammed Khan(5), Syeda Tazeen Zehra(5), Muhammad Nawaz Tahir(5), Janina Schmitz(5), Sumera Zaib(4), Daniela Häußler(4), Ulrike Bartz(4), Imtiaz Khan(3), Aamer Saeed(3), Matthias D. Mertens(3), Annett Braune(3), Michaël Blaut(3), Dilyana Dimova(3), Jörg Birkenfeld(3)